This bill gives the Secretary of Health and Human Services permanent authority to collect registration fees from members of the Organ Procurement and Transplantation Network (OPTN). It also directs the OPTN to provide a more frequent public dashboard of transplant statistics and adds explicit transparency requirements for fee receipts and uses.
The change creates a steady funding mechanism for OPTN activities by shifting the revenue source onto OPTN members and tying collections to HHS accounts. For transplant centers, organ procurement organizations, and the OPTN contractor, the bill alters budgeting dynamics and introduces new public reporting and federal oversight.
At a Glance
What It Does
Authorizes the Secretary to collect a registration fee from any OPTN member for each transplant candidate they place on the OPTN waiting list; allows HHS to collect directly or through existing awards and requires that fee receipts be treated as discretionary offsetting collections and distributed only with appropriations authorization.
Who It Affects
Transplant centers, organ procurement organizations (OPOs), histocompatibility laboratories, the OPTN contractor (currently the awardees under PHS Act section 372(b)(1)(A)), and HHS program offices that administer OPTN contracts and grants.
Why It Matters
It institutionalizes a user-fee funding model for OPTN operations, changes federal budget accounting for those activities, increases public visibility into OPTN finances and outcomes, and creates auditable oversight via a mandated Government Accountability Office (GAO) review.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill adds a new, permanent fee authority to the Public Health Service Act provision governing the Organ Procurement and Transplantation Network. Rather than relying on temporary or ad hoc funding, HHS may now charge a registration fee tied to each transplant candidate that a member lists in the OPTN system.
The statute limits the use of those funds to supporting OPTN operations and allows the money to remain available until expended, which means the funds are not swept at the end of the fiscal year and can finance multi-year program activity.
Mechanically, HHS can collect the fees in two ways: directly from members or through its existing award mechanism for the OPTN contract and related awardees. The bill specifies that collections will be credited as discretionary offsetting collections to the applicable HHS appropriation or account, a federal budget treatment that reduces net discretionary spending but still requires advance appropriations language before funds are distributed to awardees.
In practice this will require coordination between HHS budget staff, contracting offices, and appropriations committees to move money from collection to operational use.On transparency and data, the bill does two related things. First, it requires posting on the OPTN website of the amount collected from each member and a list of activities supported by those fees, updated on a quarterly basis.
Second, it expands OPTN reporting duties by directing the network to consider a dashboard that shows transplant counts, organ types that entered the system but were not transplanted, and other statistics updated more frequently than annually. Those requirements increase public-facing data but leave several design decisions—data granularity, privacy protections, and the exact update cadence—open to HHS implementation.Finally, the bill builds in external review: the GAO must conduct a review within two years and report to relevant Senate and House committees.
That review will depend on data availability from the OPTN and HHS and may be the first comprehensive assessment of how fee collection affects OPTN operations, listing practices, and allocation processes. Implementation will likely require HHS rulemaking or guidance to define fee amounts, billing timing, exemptions (if any), and enforcement mechanisms; it will also raise operational questions for member organizations about how to incorporate per-candidate fees into their internal billing and budgeting systems.
The Five Things You Need to Know
Collections are credited to the applicable HHS appropriation as discretionary offsetting collections, meaning receipts reduce net discretionary outlays but still require appropriations language to be distributed.
Collected fees 'shall be available until expended,' allowing funds to finance ongoing OPTN operations across fiscal years without year-end lapses.
HHS may collect fees either directly from OPTN members or by using awards under the existing OPTN award authority (PHS Act section 372(b)(1)(A)).
The Secretary must post, on the OPTN website, the amount of registration fees collected from each member and a list of activities supported by those fees, with updates quarterly.
The Comptroller General must conduct a GAO review within two years and report to the Senate HELP and Finance Committees and the House Energy and Commerce Committee, including recommendations as applicable.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Declares the Act's short title: 'Permanent OPTN Fee Authority Act.' This is a labeling provision but signals the statute's substantive purpose: to make fee authority permanent rather than temporary or contingent.
Reporting and dashboard language
Adjusts the existing OPTN statutory duties to add a new subparagraph directing the OPTN to 'consider establishing a dashboard' that displays transplant counts, organ types that entered the system but were not transplanted, and other statistics to be updated more frequently than annually. The provision doesn't mandate a specific update frequency or data format; instead it creates a statutory prompt for HHS and the OPTN to publish more timely performance and outcome data, while leaving operational and privacy details to implementers.
Fee authority and permitted use
Creates express authority for the Secretary to collect a registration fee from any OPTN member for each transplant candidate placed on the OPTN waiting list. The statute expressly limits fee use to supporting OPTN operations and specifies that those collections may remain available until expended—an accounting treatment that allows collected funds to carry over between fiscal years to support ongoing program costs.
Collection mechanism and distribution controls
Permits HHS to collect fees directly or through awards under the existing award authority governing the OPTN contract. It directs that funds collected be credited as discretionary offsetting collections to the appropriate HHS account, and conditions distribution of those funds to awardees on later appropriation language. Practically, this separates receipt from obligational authority: HHS can collect funds but cannot obligate or distribute them to awardees without appropriations action.
Transparency requirements and GAO review
Requires quarterly public posting of amounts collected from each OPTN member and a list of supported activities on the OPTN website, increasing direct transparency into who pays and how fees are spent. Also mandates a GAO review and report to specified Senate and House committees within two years, creating an oversight checkpoint to assess how fee collection affects OPTN activities and whether statutory objectives are being met.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- OPTN awardees and contract operators: Gain a more predictable funding stream (collections remain available until expended) to support multi-year program operations and investments.
- Researchers and policy analysts: Receive more frequent, public transplant data via the dashboard and quarterly fee postings, improving the ability to analyze system performance and access issues.
- Patients and transplant advocates: Potential indirect benefit from stronger OPTN operations and publicly available performance metrics that increase accountability and transparency.
- HHS program offices: Obtain a clearer, dedicated revenue source to finance OPTN administration without relying solely on annual appropriations for operational continuity.
Who Bears the Cost
- OPTN members (transplant centers, OPOs, histocompatibility labs): Face direct new fees tied to each transplant candidate they list; this alters operating budgets and may affect listing strategies.
- Smaller transplant programs and OPOs: Likely to feel disproportionate financial strain relative to larger centers if fees are assessed per candidate without scalable exemptions or caps.
- HHS administrative units: Must establish fee collection, accounting, and reporting processes and coordinate appropriations flows, increasing near-term administrative workload and possibly requiring rulemaking resources.
- Congressional appropriations committees: Will still need to provide advance appropriations language to distribute collected funds, adding a procedural obligation to translate collections into usable program dollars.
Key Issues
The Core Tension
The central dilemma is between securing a stable, program-dedicated funding stream for OPTN operations and avoiding incentives that distort clinical listing and allocation practices: guaranteeing operational continuity pushes costs onto members and creates accounting flexibility, but doing so without detailed guardrails risks altering provider behavior and exposing member-level financial data in ways that could affect care delivery and competition.
The bill moves funding responsibility onto OPTN members while creating a budgetary structure that both constrains and enables HHS action. Crediting fees as discretionary offsetting collections reduces net discretionary outlays on paper, but the statute still requires advance appropriations for distributions to awardees.
That duality means Congress retains control over actual expenditures even as HHS gains collection authority; implementation will require careful coordination between agency budget staff and appropriators to avoid cashflow problems for OPTN operations.
The per-candidate fee model creates incentive risks. Charging by listed candidate could change listing behavior—programs might alter who they list or how they manage inactive listings to limit fees.
The statute does not specify fee-setting methodology, exemptions, or caps, nor does it define 'member' or address multi-program hospitals and shared lists. The transparency rules increase visibility but also raise privacy and competitive concerns: posting amounts per member improves accountability but could expose granular financial information about individual centers.
Finally, the GAO review is useful but contingent on data quality and availability; if HHS or the OPTN delays dashboard development or chooses coarse aggregations, the GAO's ability to assess operational impacts will be limited.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.